
#281 ‒ Longevity drugs, aging biomarkers, and updated findings from the Interventions Testing Program (ITP) | Rich Miller, M.D., Ph.D.
This podcast episode explores various aspects of aging research, including the challenges in research funding, the significance of genetically heterogeneous mouse models, the importance of genotypic diversity in biomedical research, the preference for inbred mouse models despite their limitations, the statistical test ...
